Health Care Up on Growth Optimism — Health Care Roundup
Provided by
Dow Jones
Health-care companies rose amid generally strong earnings.
Royal Philips reached a $1.1 billion settlement in the U.S. related its Respironics ventilators, and backed its full-year growth projections.
Shares of obesity-drug maker Eli Lilly rose ahead of its earnings report, which is expected to show AbbVie recovered some of the losses in the wake of the drug maker's quarterly report Friday.
Write to Rob Curran at rob.curran@dowjones.com
(END) Dow Jones Newswires
April 29, 2024 17:59 ET (21:59 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
5 Stocks to Buy While They’re Trading at Big Discounts
-
Markets Brief: Tech Stocks Lead Ahead of Nvidia Earnings
-
How Anti-Obesity Drugs Are Innovating the Healthcare Market
-
What’s Happening In the Markets This Week
-
Why Immigration Has Boosted Job Gains and the Economy
-
What to Invest in During High Inflation
-
Never Mind Market Efficiency: Are the Markets Sensible?
-
Starbucks Stock Could Use a Pick-Me-Up After Big Selloff; Is it a Buy?
-
Should You Buy and Hold an Artificial Intelligence Portfolio?
-
3 Cheap and Dependable Dividend-Growth Stocks to Buy
-
The Best Bank Stocks to Buy
-
After Earnings, Is Roblox Stock a Buy, Sell, or Fairly Valued?
-
After Earnings, Is Lyft Stock a Buy, a Sell, or Fairly Valued?
-
8 Stock Picks in the Apparel Industry
-
Baidu Earnings: Advertising Weakness Offset by Continued Growth In Cloud Business
-
Going Into Earnings, Is Target Stock a Buy, a Sell, or Fairly Valued?